Market Intel: Eye On The Prize: Drug Delivery Advances To Fuel Ophthalmic Drug Market
Executive Summary
The global market for ophthalmic drugs is expected to hit $30.5bn by 2020, fueled in part by the rise in age-related eye conditions like glaucoma, dry eye and macular degeneration. However, there is still an unmet demand for technologies that can deliver these drugs effectively and over a sustained period. This article discusses what the challenges are to developing effective ocular drug delivery systems and highlights several innovative technologies in the pipeline, designed to overcome the limitations of current ophthalmic therapies and potentially accelerate growth of the market.
You may also be interested in...
Market Intel: Nanorobots, Digital Tracking, Dose Printing: Innovative Drug Delivery Systems Will Make Precise Drug Dosing A Reality
Precision medicine delivered by novel drug delivery systems, ranging from sensors to dose printers, could eventually revolutionize the pharmaceutical industry. Although many of these technologies are years away from commercialization, their ability to provide exact dosing with slow sustained release and more targeted therapy should improve patient compliance and outcomes.
Market Intel: Minimally Invasive Procedures Gaining Traction In BPH Treatment Market
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Landmark studies of newer techniques have led the American Urological Association to update its guidelines.
Start-Up Spotlight: Tyto Care Brings Medical Exams To Homes
Israeli-based start-up Tyto Care markets TytoHome, a device that allows consumers to check their ears, breathing and temperature from home and share the findings with a clinician for remote diagnosis.